QSI
Price
$1.81
Change
+$0.09 (+5.23%)
Updated
Oct 6 closing price
Capitalization
366.52M
29 days until earnings call
SLXN
Price
$3.87
Change
-$0.06 (-1.53%)
Updated
Oct 6, 04:59 PM (EDT)
Capitalization
12.1M
Interact to see
Advertisement

QSI vs SLXN

Header iconQSI vs SLXN Comparison
Open Charts QSI vs SLXNBanner chart's image
Quantum-Si
Price$1.81
Change+$0.09 (+5.23%)
Volume$17.24M
Capitalization366.52M
Silexion Therapeutics
Price$3.87
Change-$0.06 (-1.53%)
Volume$237
Capitalization12.1M
QSI vs SLXN Comparison Chart in %
QSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
QSI vs. SLXN commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QSI is a StrongBuy and SLXN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 07, 2025
Stock price -- (QSI: $1.81 vs. SLXN: $3.87)
Brand notoriety: QSI and SLXN are both not notable
QSI represents the Medical/Nursing Services, while SLXN is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: QSI: 189% vs. SLXN: 11%
Market capitalization -- QSI: $366.52M vs. SLXN: $12.1M
QSI [@Medical/Nursing Services] is valued at $366.52M. SLXN’s [@Biotechnology] market capitalization is $12.1M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.77B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $103.3B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.58B. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QSI’s FA Score shows that 0 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • QSI’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, QSI is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QSI’s TA Score shows that 5 TA indicator(s) are bullish while SLXN’s TA Score has 5 bullish TA indicator(s).

  • QSI’s TA Score: 5 bullish, 4 bearish.
  • SLXN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both QSI and SLXN are a good buy in the short-term.

Price Growth

QSI (@Medical/Nursing Services) experienced а +30.22% price change this week, while SLXN (@Biotechnology) price change was +14.16% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +3.33%. For the same industry, the average monthly price growth was +5.67%, and the average quarterly price growth was +18.49%.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.91%. For the same industry, the average monthly price growth was +14.77%, and the average quarterly price growth was +84.62%.

Reported Earning Dates

QSI is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Medical/Nursing Services (+3.33% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Biotechnology (+6.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QSI($367M) has a higher market cap than SLXN($12.1M). QSI YTD gains are higher at: -32.963 vs. SLXN (-87.164). SLXN has higher annual earnings (EBITDA): -17.81M vs. QSI (-106.38M). QSI has more cash in the bank: 214M vs. SLXN (3.47M). SLXN has less debt than QSI: SLXN (3.7M) vs QSI (11.1M). QSI has higher revenues than SLXN: QSI (3.41M) vs SLXN (0).
QSISLXNQSI / SLXN
Capitalization367M12.1M3,033%
EBITDA-106.38M-17.81M597%
Gain YTD-32.963-87.16438%
P/E RatioN/AN/A-
Revenue3.41M0-
Total Cash214M3.47M6,174%
Total Debt11.1M3.7M300%
TECHNICAL ANALYSIS
Technical Analysis
QSISLXN
RSI
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
13%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
29%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
33%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
28%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
55%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 6 days ago
53%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
50%
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
QSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PCSA0.280.07
+30.86%
Processa Pharmaceuticals
GSBC62.411.18
+1.93%
Great Southern Bancorp
FHB24.820.21
+0.85%
First Hawaiian
QSR68.870.39
+0.57%
Restaurant Brands International
FNWD31.930.16
+0.50%
Finward Bancorp

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-1.53%
IMA - SLXN
62%
Loosely correlated
+0.12%
CELC - SLXN
50%
Loosely correlated
-5.36%
MRSN - SLXN
43%
Loosely correlated
-0.97%
CHRS - SLXN
26%
Poorly correlated
+3.66%
QSI - SLXN
25%
Poorly correlated
+5.23%
More